MabCure Inc
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, In… Read more
MabCure Inc (MBCI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2011: 0.037x
Based on the latest financial reports, MabCure Inc (MBCI) has a cash flow conversion efficiency ratio of 0.037x as of December 2011.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($145.25K) by net assets ($3.88 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MabCure Inc - Cash Flow Conversion Efficiency Trend (2008–2011)
This chart illustrates how MabCure Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MabCure Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MabCure Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Interplay Entertainment Corp
PINK:IPLY
|
-0.016x |
|
Urologix Inc
PINK:ULGX
|
0.004x |
|
Velocity Energy Inc
PINK:VCYE
|
0.001x |
|
Patient Portal Technologies Inc
PINK:PPRG
|
0.037x |
|
Pacific Conquest Holdings Inc
PINK:PCHK
|
0.007x |
|
Andatee China Marine Fuel Services
PINK:AMCF
|
0.013x |
|
CTPartners Executive Search Inc
PINK:CTPR
|
0.046x |
|
Next.e.GO N.V. Ordinary Shares
NASDAQ:EGOX
|
-0.093x |
Annual Cash Flow Conversion Efficiency for MabCure Inc (2008–2011)
The table below shows the annual cash flow conversion efficiency of MabCure Inc from 2008 to 2011.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2011-12-31 | $3.88 Million | $-61.39K | -0.016x | +64.00% |
| 2010-12-31 | $15.72 Million | $-691.80K | -0.044x | +22.75% |
| 2009-12-31 | $18.10 Million | $-1.03 Million | -0.057x | -140.35% |
| 2008-12-31 | $19.21 Million | $-455.08K | -0.024x | -- |